Table 3 Comorbidities by age groups of participants

Hypertension

10 (1,8%)

172 (31,4%)

365(66,7%)

547 (100%)

Diabetes mellitus type 2

3 (1,1%)

82 (30,7%)

182 (68,2%)

267 (100,0%)

Cardiovascular diseases

Cardiomyopathy

-

33 (28,2%)

84 (71,8%)

117 (100,0%)

Cardiomyopathy/atrial fibrillation

-

7 (14,9%)

40 (85,1%)

47 (100,0%)

Three/two-vessel coronary disease

2 (8,0%)

10 (40,0%)

13 (52,0%)

25 (100,0%)

AMI/st post MI

-

7 (33,3%)

14 (66,7%)

21 (100,0%)

Urinary system diseases

Nephropathy

-

3 (27,3%)

8 (72,7%)

10 (100,0%)

Renal insufficiency

1 (3,6%)

9 (32,1%)

18 (64,3%)

28 (100,0%)

Thyroid gland diseases

Hypothyroidism

2 (4,8%)

14 (33,3%)

26 (61,9%)

42 (100,0%)

Hyperthyroidism

2 (20,0%)

1 (10,0%)

7 (70,0%)

10 (100,0%)

Other comorbidities

Tumors

2 (5,0%)

15 (37,5%)

23 (57,5%)

40 (100,0%)

Anemia

4 (16,0%)

10 (40,0%)

11 (44,4%)

25 (100,0%)

Chronic obstructive pulmonary disease

1 (1,3%)

25 (32,1%)

52 (66,7%)

78 (100,0%)

St post stroke

1 (3,8%)

4 (15,4%)

21 (80,8%)

26 (100,0%)

Obesity

2 (12,5%)

7 (43,8%)

7 (43,8%)

16 (100,0%)